eye pain glp 1 GLP-1 Meds Reduce Risk of Uveitis Emerging Concerns: GLP-1 Modulators and

While we are disappointed to discontinue the development of danuglipron, we remain committed to evaluating and advancing promising programs in an effort to bring innovative new medicines to patients, said Chris Boshoff, Pfizers chief scientific officer and head of R&D, in a statement

Our findings demonstrate that increased mitochondrial function, acquired through mitochondrial biogenesis, is required to promote survival in response to acute 5FU treatment

Required for 500+ enzymatic reactions, NAD+ fuels cellular energy, DNA repair, and sirtuin activation

Your protocol, your pace

Friday Shorts: Drug tariffs, oral GLP-1, health care worries April 3, 2026 A

Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptordependent andindependent pathways